Argenx
ARGX
#571
Rank
NZ$62.06 B
Marketcap
$1,038
Share price
1.54%
Change (1 day)
27.03%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Total assets

Total assets on the balance sheet as of June 2024 : NZ$8.21 Billion

According to Argenx 's latest financial reports the company's total assets are NZ$8.21 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Argenx - Total assets on balance sheet (from 2021 to 2020)

Total assets by year

Year Total assets Change
2022-12-31NZ$4.93 B18.3%
2021-12-31NZ$4.17 B7.39%
2020-12-31NZ$3.88 B45.08%
2019-12-31NZ$2.67 B137.33%
2018-12-31NZ$1.12 B50.12%
2017-12-31NZ$0.75 B345.05%
2016-12-31NZ$0.16 B110.42%
2015-12-31NZ$80.27 M-27.31%
2014-12-31NZ$0.11 B90.26%
2013-12-31NZ$58.04 M57.43%
2012-12-31NZ$36.86 M-30.63%
2011-12-31NZ$53.14 M151.41%
2010-12-31NZ$21.13 M